» Articles » PMID: 33134888

SARS-CoV-2 Targets by the PscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases

Overview
Journal iScience
Publisher Cell Press
Date 2020 Nov 2
PMID 33134888
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The cellular targets of SARS-CoV-2, the novel coronavirus causing the COVID-19 pandemic, is still rudimentary. Here, we incorporated the protein information to analyze the expression of ACE2, the SARS-CoV-2 receptor, together with co-factors, TMPRSS2 and Furin, at single-cell level , which we called protein-proofed single-cell RNA (pscRNA) profiling. Systemic analysis across 36 tissues revealed a rank list of candidate cells potentially vulnerable to SARS-CoV-2. The top targets are lung AT2 cells and macrophages, then cardiomyocytes and adrenal gland stromal cells, followed by stromal cells in testis, ovary, and thyroid, whereas the kidney proximal tubule cells, cholangiocytes, and enterocytes are less likely to be the primary SARS-CoV-2 targets. Actually, the stomach may constitute a physical barrier against SARS-CoV-2 as the acidic environment (pH < 2.0) could completely inactivate SARS-CoV-2 pseudo-viruses. Together, we provide a comprehensive view on the potential SARS-CoV-2 targets by pscRNA profiling.

Citing Articles

Risk impact of SARS-CoV-2 coronavirus and spike protein on cardiac tissue: a comprehensive review.

Sery O, Dziedzinska R Physiol Res. 2025; 73(S3):S655-S669.

PMID: 39808169 PMC: 11827061. DOI: 10.33549/physiolres.935476.


The inactivation of the Niemann Pick C1 cholesterol transporter restricts SARS-CoV-2 entry into host cells by decreasing ACE2 abundance at the plasma membrane.

La Rosa P, Tiberi J, Palermo E, Stefanelli R, Tiano S, Canterini S Cell Biosci. 2024; 14(1):148.

PMID: 39707537 PMC: 11662611. DOI: 10.1186/s13578-024-01331-4.


Pathological Sequelae of SARS-CoV-2: A Review for Clinicians.

Nyarko J, Dogbe P, Ativi L, Wutsika J, Agyenim E, Awere-Duodu A Yale J Biol Med. 2024; 97(4):431-445.

PMID: 39703609 PMC: 11650917. DOI: 10.59249/DQJH2274.


Identification of COVID-19-Associated Hepatitis in Children as an Emerging Complication in the Wake of SARS-CoV-2 Infections: Ambispective Observational Study.

Rawat S, Asati A, Mishra N, Jain A, Ratho R JMIRx Med. 2024; 5:e48629.

PMID: 39392692 PMC: 11488459. DOI: 10.2196/48629.


Infectious Diseases.

Li H, Terrando N, Gelbard H Adv Neurobiol. 2024; 37:423-444.

PMID: 39207706 PMC: 11556852. DOI: 10.1007/978-3-031-55529-9_24.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Zhou B, She J, Wang Y, Ma X . The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease. J Infect. 2020; 81(1):147-178. PMC: 7163185. DOI: 10.1016/j.jinf.2020.03.021. View

3.
Korber B, Fischer W, Gnanakaran S, Yoon H, Theiler J, Abfalterer W . Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020; 182(4):812-827.e19. PMC: 7332439. DOI: 10.1016/j.cell.2020.06.043. View

4.
Ziegler C, Allon S, Nyquist S, Mbano I, Miao V, Tzouanas C . SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020; 181(5):1016-1035.e19. PMC: 7252096. DOI: 10.1016/j.cell.2020.04.035. View

5.
Millet J, Whittaker G . Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2014; 202:120-34. PMC: 4465284. DOI: 10.1016/j.virusres.2014.11.021. View